Back to Search
Start Over
Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies.
- Source :
-
Gastroenterology [Gastroenterology] 2021 Aug; Vol. 161 (2), pp. 715-718.e4. Date of Electronic Publication: 2021 Apr 20. - Publication Year :
- 2021
- Subjects :
- 2019-nCoV Vaccine mRNA-1273
Adult
Aged
BNT162 Vaccine
Case-Control Studies
Female
Humans
Immunoglobulin G blood
Male
Middle Aged
RNA, Messenger
SARS-CoV-2 immunology
Spike Glycoprotein, Coronavirus genetics
Young Adult
Antibodies, Viral blood
Biological Products therapeutic use
COVID-19 prevention & control
COVID-19 Vaccines immunology
Inflammatory Bowel Diseases drug therapy
Spike Glycoprotein, Coronavirus immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1528-0012
- Volume :
- 161
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Gastroenterology
- Publication Type :
- Academic Journal
- Accession number :
- 33887219
- Full Text :
- https://doi.org/10.1053/j.gastro.2021.04.025